|
|
.
See Category: Factors influencing health status and contact with health services
See Header: Encntr screen for malignant neoplasm of intestinal tract
ICD-10 (CM) Code and Descriptor
|
Z12.13 |
Encounter for screening for malignant neoplasm of small intestine
This code is considered unacceptable as a principal diagnosis.
|
Z1213 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 50.00%
|
22.50%
|
7.50%
|
5.83%
|
3.33%
|
4.17%
|
3.06%
|
0.56%
|
1.11%
|
0.28%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z12.13*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
77067
|
SCR MAMMO BI INCL CAD |
77
|
77
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
74
|
1,640
|
|
77063
|
BREAST TOMOSYNTHESIS BI |
66
|
66
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
55
|
92
|
|
43239
|
EGD BIOPSY SINGLE/MULTIPLE |
42
|
42
|
|
J7030
|
NORMAL SALINE SOLUTION INFUS |
29
|
34
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
25
|
61
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
19
|
19
|
|
77080
|
DXA BONE DENSITY AXIAL |
18
|
18
|
|
J7120
|
RINGERS LACTATE INFUSION |
18
|
18
|
|
J3010
|
FENTANYL CITRATE INJECTION |
17
|
19
|
|
43235
|
EGD DIAGNOSTIC BRUSH WASH |
14
|
14
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
11
|
11
|
|
J2001
|
LIDOCAINE INJECTION |
10
|
86
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
10
|
18
|
|
80053
|
COMPREHEN METABOLIC PANEL |
9
|
9
|
|
80061
|
LIPID PANEL |
8
|
8
|
|
99212
|
OFFICE O/P EST SF 10 MIN |
8
|
8
|
|
G2025
|
DIS SITE TELE SVCS RHC/FQHC |
8
|
8
|
|
82962
|
GLUCOSE BLOOD TEST |
8
|
10
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z12.13 related to the following DRG Codes:
951
|
